SlideShare une entreprise Scribd logo
1  sur  26
Télécharger pour lire hors ligne
STRUCTURE ACTIVITY
RELATIONSHIP
Abdul Samad
Dr. Syed Badshah
1
 Structure
 Activity
 SAR (Discussion/Elaboration)
Contents
2
3
Crude drug Structure Ligand bindingReceptor
Biological
response
4
CHEMICAL STRUCTURE
 A chemical structure includes molecular geometry,
electronic structure, and crystal structure of a molecule.
BIOLOGICALACTIVITY
 Biological activity is an expression describing the beneficial
or adverse effects of a drug on living matter.
5
STRUCTURE ACTIVITY RELATIONSHIP
 The relationship between the chemical or 3D
structure of a molecule and its biological activity.
Enables the determination of the chemical groups
responsible for evoking a target biological effect in
the organism.
6
WHY SAR Exist?
• The interaction of the drug molecule with protein depends
on its chemical structure
NEED OF SAR STUDY
• A study of the structure–activity relationship is mainly
done by lead molecule.
• It is used to determine pharmacophore, unwanted side
effects
• To develop a new drug that has increased activity.
7
Cont.…..
• To determine some different activity from an
existing drug
• To fewer unwanted side effects
• To know the changes in pharmacological properties
by performing minor changes in the drug molecule
8
SAR (DISCUSSION/ELABORATION)
FFFFFFFFFFFFFFFFFollowing
cALKALOIDSCFLAVONOIDS TERPENOIDS
9
TAXOL CPT
10
Camptothecin
(CPT)
WALL & WANI in
early Sixties
Camptotheca
cuminata,Tree of
Joy, Love
Quinolino
alkaloid
Pentacyclic
ring
structure
11
STRUCTURE OF CPT WITH IUPAC
NAME
12
A B C
D
E
Rings A–D are essential for activity. Saturation of ring B< activity
necessary for activity
essential for activity, S N
inactive
D-ring pyridone is required for anti
tumor activity.
 Modifications in rings A, B are well tolerated
The stereochemistry at C-20 is very crucial as
20(S) hydroxyl is active, 20(R) inactive
modifications at the C , D rings led
to complete loss of cytotoxicity.
13
Modification in rings A,B
Topotecan
Irinotecan
14
Modification in rings C,D
 In general, modifications at the C and D rings of
camptothecin led to complete loss of cytotoxicity.
 If we see these rings, the only positions available
for modifications are C-5, C-14 and C-17. Several
derivatives have been reported either with less
activity or with loss of activity.
15
Modification in ring E
 The α- hydroxyl lactone system of ring E has been
found to be important for the inhibition of the
topoisomerase enzyme as well as for in vivo
potency
 Derivatives having a lactam group instead of a
lactone, were devoid of topoisomerase inhibitor
activity.
16
17
TAXOL
Taxol, paclitaxel, trade name taxol,
by Dr. WALL and Dr. WANI
Complex
polyoxygenated
diterpenoid
Pacific yew, Taxus
brevifolia
basic [9.3.1.0]
Pentadecane, tetracyclic
ring system.
N-benzoyl-b-phenyl
isoserine side chain, at
the C-13 hydroxyl as an
ester linkage.
18
STRUCTURE OF TAXOL WITH IUPAC NAME
19
Oxitane ring essential
Ester, Amino
ester,epimer,deoxy =
active
Reduction enhance activity
Removal of acetyl < activity
Phenyl isoserine chain essential for activity
N-acyl group, required
Aryl group, essential
Free OH active in both(in vivo, in vitro)
Ester only in vivo
The C-3’aryl group is required for better
activity, methyl group, activity is reduced19-
fold.
northern and southern hemispheres.
modifications in the southern hemisphere are strictly forbidden
while in the northern hemisphere are allowed
20
C-13 SIDE CHAIN
 C-13 side chain is essentially required for anticancer
activity. The C-2’-hydroxyl is important for activity.
 When this hydroxyl is protected, activity is reduced to a
great extent and if the protection is made with a labile
group it shows similar activity in vivo, while no activity is
shown in in vitro testing
21
FLAVONOIDS
QUERCETIN
22
23
The main structural features of flavonoids required for
efficient radical scavenging could be summarized as
i. An ortho-dihydroxy (catechol) structure in the B
ring, for electron delocalization
24
 2,3-double bond in conjugation with a 4-oxo function in
the C ring provides electron delocalization from the B ring
25
 Hydroxyl groups at positions 3 and 5 provide hydrogen
bonding to the Oxo group
26
THANK YOU

Contenu connexe

Tendances

QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDGagangowda58
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysisASHOK GAUTAM
 
BIOISOSTERSM
BIOISOSTERSMBIOISOSTERSM
BIOISOSTERSMTuba Khan
 
Prodrugs - concept & Applications
Prodrugs - concept & ApplicationsProdrugs - concept & Applications
Prodrugs - concept & ApplicationsJanet Thomas
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug designProf. Aejaz Ahmed Boraji
 
Principles and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity RelationshipPrinciples and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity RelationshipNizam Ashraf
 
Hansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsHansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsAkshay Kank
 
Pharmacophore modeling
Pharmacophore modelingPharmacophore modeling
Pharmacophore modelingDevika Rana
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistryMohit umare
 
Analog design bioisosterism
Analog design bioisosterismAnalog design bioisosterism
Analog design bioisosterismPraba karan
 
PRODRUG DESIGN [M.PHARM]
PRODRUG DESIGN [M.PHARM]PRODRUG DESIGN [M.PHARM]
PRODRUG DESIGN [M.PHARM]Shikha Popali
 
Opiod Structure Activity Relationship
Opiod Structure Activity RelationshipOpiod Structure Activity Relationship
Opiod Structure Activity RelationshipSuji Susanth
 

Tendances (20)

QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
 
QSAR
QSARQSAR
QSAR
 
Free wilson analysis
Free wilson analysisFree wilson analysis
Free wilson analysis
 
BIOISOSTERSM
BIOISOSTERSMBIOISOSTERSM
BIOISOSTERSM
 
Qsar
QsarQsar
Qsar
 
Prodrugs - concept & Applications
Prodrugs - concept & ApplicationsProdrugs - concept & Applications
Prodrugs - concept & Applications
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug design
 
Principles and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity RelationshipPrinciples and Applications of Structure Activity Relationship
Principles and Applications of Structure Activity Relationship
 
Drug design
Drug designDrug design
Drug design
 
Hansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR ModelsHansch and Free-Wilson QSAR Models
Hansch and Free-Wilson QSAR Models
 
Pharmacophore modeling
Pharmacophore modelingPharmacophore modeling
Pharmacophore modeling
 
Medicinal chemistry
Medicinal chemistry Medicinal chemistry
Medicinal chemistry
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
 
Analog design bioisosterism
Analog design bioisosterismAnalog design bioisosterism
Analog design bioisosterism
 
QSAR
QSARQSAR
QSAR
 
PRODRUG DESIGN [M.PHARM]
PRODRUG DESIGN [M.PHARM]PRODRUG DESIGN [M.PHARM]
PRODRUG DESIGN [M.PHARM]
 
Qsar parameter
Qsar parameterQsar parameter
Qsar parameter
 
Opiod Structure Activity Relationship
Opiod Structure Activity RelationshipOpiod Structure Activity Relationship
Opiod Structure Activity Relationship
 
3. stereochemistry of steroids
3. stereochemistry of steroids3. stereochemistry of steroids
3. stereochemistry of steroids
 
Prodrug
ProdrugProdrug
Prodrug
 

Similaire à Structure activity relationship 6

DR. THIRUMALAI Unit_I_3_leadOptimization.ppt
DR. THIRUMALAI Unit_I_3_leadOptimization.pptDR. THIRUMALAI Unit_I_3_leadOptimization.ppt
DR. THIRUMALAI Unit_I_3_leadOptimization.pptssuserf14ecf
 
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCESPEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCESSagarMudgil1
 
Scaffold hopping in drug development ppt
Scaffold hopping in drug development  pptScaffold hopping in drug development  ppt
Scaffold hopping in drug development pptAkliluSamuel3
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdfShivalingMP
 
BMCL_2006_LSmithII
BMCL_2006_LSmithIIBMCL_2006_LSmithII
BMCL_2006_LSmithIILeon Smith
 
Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011Alex Kiselyov
 
Ezetimibe and Other Beta Lactams SAR Degradation.pptx
Ezetimibe and Other Beta Lactams SAR Degradation.pptxEzetimibe and Other Beta Lactams SAR Degradation.pptx
Ezetimibe and Other Beta Lactams SAR Degradation.pptxKumarNeeraj13
 
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal ChemistryFUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal ChemistryPRUTHVIRAJ K
 
Structural Studies of Human GBE1 and Relevance to APBD
Structural Studies of Human GBE1 and Relevance to APBDStructural Studies of Human GBE1 and Relevance to APBD
Structural Studies of Human GBE1 and Relevance to APBDBen Decker
 
ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5Kaitlin Hart
 
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUKBIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUKSagarMudgil1
 
Rubisco Lab Report
Rubisco Lab ReportRubisco Lab Report
Rubisco Lab ReportTammy Lacy
 

Similaire à Structure activity relationship 6 (20)

analog design.pptx
analog design.pptxanalog design.pptx
analog design.pptx
 
DR. THIRUMALAI Unit_I_3_leadOptimization.ppt
DR. THIRUMALAI Unit_I_3_leadOptimization.pptDR. THIRUMALAI Unit_I_3_leadOptimization.ppt
DR. THIRUMALAI Unit_I_3_leadOptimization.ppt
 
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCESPEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
PEPTIDOMIMETICS/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES
 
Rational Drug design
Rational Drug designRational Drug design
Rational Drug design
 
Scaffold hopping in drug development ppt
Scaffold hopping in drug development  pptScaffold hopping in drug development  ppt
Scaffold hopping in drug development ppt
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
 
Drug design
Drug designDrug design
Drug design
 
BMCL_2006_LSmithII
BMCL_2006_LSmithIIBMCL_2006_LSmithII
BMCL_2006_LSmithII
 
DRUG-DESIGN.docx
DRUG-DESIGN.docxDRUG-DESIGN.docx
DRUG-DESIGN.docx
 
Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011Polyalkoxybenzenes JMC2011
Polyalkoxybenzenes JMC2011
 
Ezetimibe and Other Beta Lactams SAR Degradation.pptx
Ezetimibe and Other Beta Lactams SAR Degradation.pptxEzetimibe and Other Beta Lactams SAR Degradation.pptx
Ezetimibe and Other Beta Lactams SAR Degradation.pptx
 
Nos2003 conner
Nos2003 connerNos2003 conner
Nos2003 conner
 
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal ChemistryFUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
FUNCTIONAL GROUP MODIFICATION : Medicinal Chemistry
 
Structural Studies of Human GBE1 and Relevance to APBD
Structural Studies of Human GBE1 and Relevance to APBDStructural Studies of Human GBE1 and Relevance to APBD
Structural Studies of Human GBE1 and Relevance to APBD
 
paper1-published
paper1-publishedpaper1-published
paper1-published
 
ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5ASBMB Poster_16April2014_Draft5
ASBMB Poster_16April2014_Draft5
 
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUKBIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
BIOCATALYST/SAGAR SHARMA/DEPARTMENT OF PHARMACEUTICAL SCIENCES KUK
 
Enzymes
EnzymesEnzymes
Enzymes
 
7.6 enzymes
7.6 enzymes7.6 enzymes
7.6 enzymes
 
Rubisco Lab Report
Rubisco Lab ReportRubisco Lab Report
Rubisco Lab Report
 

Dernier

Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...DhatriParmar
 
Indexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdfIndexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdfChristalin Nelson
 
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
Unraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptxUnraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptx
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptxDhatriParmar
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQuiz Club NITW
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxSayali Powar
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationdeepaannamalai16
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDhatriParmar
 
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxCLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxAnupam32727
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17Celine George
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptxmary850239
 
Sulphonamides, mechanisms and their uses
Sulphonamides, mechanisms and their usesSulphonamides, mechanisms and their uses
Sulphonamides, mechanisms and their usesVijayaLaxmi84
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6Vanessa Camilleri
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseCeline George
 
Tree View Decoration Attribute in the Odoo 17
Tree View Decoration Attribute in the Odoo 17Tree View Decoration Attribute in the Odoo 17
Tree View Decoration Attribute in the Odoo 17Celine George
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 

Dernier (20)

Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
Blowin' in the Wind of Caste_ Bob Dylan's Song as a Catalyst for Social Justi...
 
Indexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdfIndexing Structures in Database Management system.pdf
Indexing Structures in Database Management system.pdf
 
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
Unraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptxUnraveling Hypertext_ Analyzing  Postmodern Elements in  Literature.pptx
Unraveling Hypertext_ Analyzing Postmodern Elements in Literature.pptx
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITWQ-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
Q-Factor HISPOL Quiz-6th April 2024, Quiz Club NITW
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
 
Congestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentationCongestive Cardiac Failure..presentation
Congestive Cardiac Failure..presentation
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 
Faculty Profile prashantha K EEE dept Sri Sairam college of Engineering
Faculty Profile prashantha K EEE dept Sri Sairam college of EngineeringFaculty Profile prashantha K EEE dept Sri Sairam college of Engineering
Faculty Profile prashantha K EEE dept Sri Sairam college of Engineering
 
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptxDecoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
Decoding the Tweet _ Practical Criticism in the Age of Hashtag.pptx
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptxCLASSIFICATION OF ANTI - CANCER DRUGS.pptx
CLASSIFICATION OF ANTI - CANCER DRUGS.pptx
 
How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17How to Fix XML SyntaxError in Odoo the 17
How to Fix XML SyntaxError in Odoo the 17
 
4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx4.11.24 Poverty and Inequality in America.pptx
4.11.24 Poverty and Inequality in America.pptx
 
Sulphonamides, mechanisms and their uses
Sulphonamides, mechanisms and their usesSulphonamides, mechanisms and their uses
Sulphonamides, mechanisms and their uses
 
ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6ICS 2208 Lecture Slide Notes for Topic 6
ICS 2208 Lecture Slide Notes for Topic 6
 
How to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 DatabaseHow to Make a Duplicate of Your Odoo 17 Database
How to Make a Duplicate of Your Odoo 17 Database
 
Tree View Decoration Attribute in the Odoo 17
Tree View Decoration Attribute in the Odoo 17Tree View Decoration Attribute in the Odoo 17
Tree View Decoration Attribute in the Odoo 17
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 

Structure activity relationship 6

  • 2.  Structure  Activity  SAR (Discussion/Elaboration) Contents 2
  • 3. 3 Crude drug Structure Ligand bindingReceptor Biological response
  • 4. 4 CHEMICAL STRUCTURE  A chemical structure includes molecular geometry, electronic structure, and crystal structure of a molecule. BIOLOGICALACTIVITY  Biological activity is an expression describing the beneficial or adverse effects of a drug on living matter.
  • 5. 5 STRUCTURE ACTIVITY RELATIONSHIP  The relationship between the chemical or 3D structure of a molecule and its biological activity. Enables the determination of the chemical groups responsible for evoking a target biological effect in the organism.
  • 6. 6 WHY SAR Exist? • The interaction of the drug molecule with protein depends on its chemical structure NEED OF SAR STUDY • A study of the structure–activity relationship is mainly done by lead molecule. • It is used to determine pharmacophore, unwanted side effects • To develop a new drug that has increased activity.
  • 7. 7 Cont.….. • To determine some different activity from an existing drug • To fewer unwanted side effects • To know the changes in pharmacological properties by performing minor changes in the drug molecule
  • 10. 10 Camptothecin (CPT) WALL & WANI in early Sixties Camptotheca cuminata,Tree of Joy, Love Quinolino alkaloid Pentacyclic ring structure
  • 11. 11 STRUCTURE OF CPT WITH IUPAC NAME
  • 12. 12 A B C D E Rings A–D are essential for activity. Saturation of ring B< activity necessary for activity essential for activity, S N inactive D-ring pyridone is required for anti tumor activity.  Modifications in rings A, B are well tolerated The stereochemistry at C-20 is very crucial as 20(S) hydroxyl is active, 20(R) inactive modifications at the C , D rings led to complete loss of cytotoxicity.
  • 13. 13 Modification in rings A,B Topotecan Irinotecan
  • 14. 14 Modification in rings C,D  In general, modifications at the C and D rings of camptothecin led to complete loss of cytotoxicity.  If we see these rings, the only positions available for modifications are C-5, C-14 and C-17. Several derivatives have been reported either with less activity or with loss of activity.
  • 15. 15 Modification in ring E  The α- hydroxyl lactone system of ring E has been found to be important for the inhibition of the topoisomerase enzyme as well as for in vivo potency  Derivatives having a lactam group instead of a lactone, were devoid of topoisomerase inhibitor activity.
  • 16. 16
  • 17. 17 TAXOL Taxol, paclitaxel, trade name taxol, by Dr. WALL and Dr. WANI Complex polyoxygenated diterpenoid Pacific yew, Taxus brevifolia basic [9.3.1.0] Pentadecane, tetracyclic ring system. N-benzoyl-b-phenyl isoserine side chain, at the C-13 hydroxyl as an ester linkage.
  • 18. 18 STRUCTURE OF TAXOL WITH IUPAC NAME
  • 19. 19 Oxitane ring essential Ester, Amino ester,epimer,deoxy = active Reduction enhance activity Removal of acetyl < activity Phenyl isoserine chain essential for activity N-acyl group, required Aryl group, essential Free OH active in both(in vivo, in vitro) Ester only in vivo The C-3’aryl group is required for better activity, methyl group, activity is reduced19- fold. northern and southern hemispheres. modifications in the southern hemisphere are strictly forbidden while in the northern hemisphere are allowed
  • 20. 20 C-13 SIDE CHAIN  C-13 side chain is essentially required for anticancer activity. The C-2’-hydroxyl is important for activity.  When this hydroxyl is protected, activity is reduced to a great extent and if the protection is made with a labile group it shows similar activity in vivo, while no activity is shown in in vitro testing
  • 22. 22
  • 23. 23 The main structural features of flavonoids required for efficient radical scavenging could be summarized as i. An ortho-dihydroxy (catechol) structure in the B ring, for electron delocalization
  • 24. 24  2,3-double bond in conjugation with a 4-oxo function in the C ring provides electron delocalization from the B ring
  • 25. 25  Hydroxyl groups at positions 3 and 5 provide hydrogen bonding to the Oxo group